These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22083001)

  • 21. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
    Hata JS; Fick RB
    Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clues to mechanism of Pseudomonas resistance in cystic fibrosis.
    Lawrence D
    Lancet; 2002 Apr; 359(9315):1410. PubMed ID: 11978345
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antibiotic therapy against Pseudomonas aeruginosa and other gram-negative bacteria in cystic fibrosis].
    Le Bourgeois M
    Arch Pediatr; 2003 Sep; 10 Suppl 2():352s-357s. PubMed ID: 14671934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas colonization in cystic fibrosis. A study of 160 patients.
    Kulczycki LL; Murphy TM; Bellanti JA
    JAMA; 1978 Jul; 240(1):30-4. PubMed ID: 96277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies.
    Høiby N
    J Cyst Fibros; 2002 Dec; 1(4):249-54. PubMed ID: 15463822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pseudomonas aeruginosa Population among Cystic Fibrosis Patients in Quebec, Canada: a Disease Hot Spot without Known Epidemic Isolates.
    Jeukens J; Freschi L; Kukavica-Ibrulj I; Emond-Rheault JG; Allard C; Barbeau J; Cantin A; Charette SJ; Déziel E; Malouin F; Milot J; Nguyen D; Popa C; Boyle B; Levesque RC
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944192
    [No Abstract]   [Full Text] [Related]  

  • 29. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
    PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mathematical modelling of Pseudomonas aeruginosa biofilm growth and treatment in the cystic fibrosis lung.
    Miller JK; Brantner JS; Clemons C; Kreider KL; Milsted A; Wilber P; Yun YH; Youngs WJ; Young G; Badawy HT; Milsted A; Clemons C; Kreider KL; Wilber P; Young G; Yun YH; Wagers PO; Youngs WJ
    Math Med Biol; 2014 Jun; 31(2):179-204. PubMed ID: 23518337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological investigation and glycotyping of clinical Pseudomonas aeruginosa isolates from patients with cystic fibrosis by mass spectrometry: association with multiple drug resistance.
    Altman E; Wang Z; Aaron SD; Liu X; Vandemheen KL; Ferris W; Giesbrecht T; Li J
    J Microbiol Methods; 2009 Feb; 76(2):204-8. PubMed ID: 19000720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa biofilms in a bronchoalveolar lavage.
    Pusztaszeri M; Aubert JD; Braunschweig R; Mihaescu A
    Diagn Cytopathol; 2009 Nov; 37(11):825. PubMed ID: 19191299
    [No Abstract]   [Full Text] [Related]  

  • 33. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 34. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.
    Maurice NM; Bedi B; Sadikot RT
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):428-439. PubMed ID: 29372812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
    Lahiri T
    Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.
    Pier GB
    J Infect Dis; 1985 Apr; 151(4):575-80. PubMed ID: 3919113
    [No Abstract]   [Full Text] [Related]  

  • 37. Motility as a selective force in the reversion of cystic fibrosis-associated mucoid Pseudomonas aeruginosa to the nonmucoid phenotype in culture.
    Boyce JR; Miller RV
    Infect Immun; 1982 Aug; 37(2):840-4. PubMed ID: 6811443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication of Pseudomonas aeruginosa in cystic fibrosis patients.
    Döring G; Taccetti G; Campana S; Festini F; Mascherini M
    Eur Respir J; 2006 Mar; 27(3):653. PubMed ID: 16507869
    [No Abstract]   [Full Text] [Related]  

  • 40. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
    Eber E; Thalhammer GH; Zach MS
    Eur Respir J; 2006 Feb; 27(2):438-9. PubMed ID: 16452606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.